International Stem Cell Corp. (ISCO) Helps Advance Science via Lifeline Cell Technology Subsidiary

The Lifeline Cell Technology subsidiary of International Stem Cell Corp. specializes in the development and manufacture of purified primary human cells and optimized reagents for cell culture. The company’s scientists continue to come up with new and improved human cell systems for the worldwide culture marketplace and are making breakthroughs in the development of human stem cell production. Their strength rests in both the established quality and range of their products, which are listed below.

Cell Types:

• Endothelial
• Epithelial
• Fibroblast
• Hepatocytes
• Melanocytes
• Mononuclear
• Neuronal
• Smooth muscle
• Stem cells, human
• Stem cells, non-human

Tissue Types:

• Blood Immune System
• Endothelial-Large Vessel
• Endothelial-Small Vessel
• Epithelial
• Fibroblast
• Hepatocytes
• Neuronal
• Smooth muscle
• Stem cells, human

Cell Culture Media:

• Blood Immune System
• Endothelial-Large Vessel
• Endothelial-Small Vessel
• Epithelial
• Fibroblast
• Hepatocytes
• Neuronal
• Smooth muscle
• Stem cells, human

Additional Products:

• Reagents, supplements and growth factors
• Skin models
• Stem Cell Differentiation Kits

For additional information, visit www.InternationalStemCell.com and www.LifelineSkinCare.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The QualityStocks Daily Blog http://blog.qualitystocks.net

The QualityStocks Video Charts http://videocharts.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net